Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)
Close on Nov 17, 2026Market cap $9.38MP/E –Yield –
Femasys revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Femasys's revenue for the twelve months ending Jun 30, 2026 was $2.30M, up 21.9% year over year. For fiscal 2025 it was $2.29M, up 40.8% from the year before. The highest annual figure on record is $2.29M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.29M | +40.8% |
| FY2024 | Dec 31, 2024 | $1.63M | +52.0% |
| FY2023 | Dec 31, 2023 | $1.07M | -11.1% |
| FY2022 | Dec 31, 2022 | $1.21M | +2.2% |
| FY2021 | Dec 31, 2021 | $1.18M | +13.7% |
| FY2020 | Dec 31, 2020 | $1.04M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $331.83K | -18.9% |
| Q1 FY2026 | Mar 31, 2026 | $424.89K | +24.5% |
| Q4 FY2025 | Dec 31, 2025 | $813.39K | +39.9% |
| Q3 FY2025 | Sep 30, 2025 | $729.39K | +31.4% |
| Q2 FY2025 | Jun 30, 2025 | $409.27K | +84.8% |
| Q1 FY2025 | Mar 31, 2025 | $341.26K | +25.9% |
| Q4 FY2024 | Dec 31, 2024 | $581.58K | +172.9% |
| Q3 FY2024 | Sep 30, 2024 | $554.91K | +127.1% |
| Q2 FY2024 | Jun 30, 2024 | $221.48K | -30.9% |
| Q1 FY2024 | Mar 31, 2024 | $271.14K | -7.8% |
| Q4 FY2023 | Dec 31, 2023 | $213.11K | -9.0% |
| Q3 FY2023 | Sep 30, 2023 | $244.36K | -29.7% |
| Q2 FY2023 | Jun 30, 2023 | $320.51K | +5.7% |
| Q1 FY2023 | Mar 31, 2023 | $293.98K | -8.5% |
| Q4 FY2022 | Dec 31, 2022 | $234.24K | -7.9% |
| Q3 FY2022 | Sep 30, 2022 | $347.46K | +28.9% |
| Q2 FY2022 | Jun 30, 2022 | $303.11K | -7.0% |
| Q1 FY2022 | Mar 31, 2022 | $321.41K | -2.5% |
| Q4 FY2021 | Dec 31, 2021 | $254.33K | -9.5% |
| Q3 FY2021 | Sep 30, 2021 | $269.58K | -13.9% |
| Q2 FY2021 | Jun 30, 2021 | $326.01K | +77.9% |
| Q1 FY2021 | Mar 31, 2021 | $329.78K | – |
| Q4 FY2020 | Dec 31, 2020 | $280.96K | – |
| Q3 FY2020 | Sep 30, 2020 | $313.21K | – |
| Q2 FY2020 | Jun 30, 2020 | $183.23K | – |
See a number that looks wrong?